Hurricane hits healthcare reform
Washington, D.C.— The floodwaters of Hurricane Katrina destroyed hospitals, washed out medical records and separated thousands of patients from doctors and from nursing homes. Biomedical research labs at Tulane and other New Orleans universities have been devastated by the loss of research animals and frozen tissues, as well as extensive data files.
WASHINGTON, D.C.- The floodwaters of Hurricane Katrina destroyed hospitals, washed out medical records and separated thousands of patients from doctors and from nursing homes. Biomedical research labs at Tulane and other New Orleans universities have been devastated by the loss of research animals and frozen tissues, as well as extensive data files.
On the policy front, Republican plans to cut $10 billion over five years from the Medicaid program were put on hold as states struggled to provide care for thousands of evacuees. Medicaid officials are trying to make it easier for people from the Gulf region to qualify for healthcare services in other states, including coverage of prescription drug refills, vaccinations and insulin products. Hurricane victims don't have to document income eligibility or show previous coverage to gain Medicaid services.
Some members of Congress also would like to delay current plans to shift drug coverage for poor elderly patients from Medicaid to the new Medicare drug program, which will take affect January 1. The process for changing coverage of these dual-eligible seniors is in the works, though, and likely to continue.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
